Characterization of recombinant camel chymosin reveals superior properties for the coagulation of bovine and camel milk.

Enzymatic milk coagulation for cheese manufacturing involves the cleavage of the scissile bond in kappa-casein by an aspartic acid protease. Bovine chymosin is the preferred enzyme, combining a strong clotting activity with a low general proteolytic activity. In the present study, we report expression and enzymatic properties of recombinant camel chymosin expressed in Aspergillus niger. Camel chymosin was shown to have different characteristics than bovine chymosin. Camel chymosin exhibits a 70% higher clotting activity for bovine milk and has only 20% of the unspecific protease activity for bovine chymosin. This results in a sevenfold higher ratio of clotting to general proteolytic activity. The enzyme is more thermostable than bovine chymosin. Kinetic analysis showed that half-saturation is achieved with less than 50% of the substrate required for bovine chymosin and turnover rates are lower. While raw camel milk cannot be clotted with bovine chymosin, a high clotting activity was found with camel chymosin.

Pepsinogens, progastricsins, and prochymosins: structure, function, evolution, and development.

Five types of zymogens of pepsins, gastric digestive proteinases, are known: pepsinogens A, B, and F, progastricsin, and prochymosin. The amino acid and/or nucleotide sequences of more than 50 pepsinogens other than pepsinogen B have been determined to date. Phylogenetic analyses based on these sequences indicate that progastricsin diverged first followed by prochymosin, and that pepsinogens A and F are most closely related. Tertiary structures, clarified by X-ray crystallography, are commonly bilobal with a large active-site cleft between the lobes. Two aspartates in the center of the cleft, Asp32 and Asp215, function as catalytic residues, and thus pepsinogens are classified as aspartic proteinases. Conversion of pepsinogens to pepsins proceeds autocatalytically at acidic pH by two different pathways, a one-step pathway to release the intact activation segment directly, and a stepwise pathway through a pseudo-pepsin(s). The active-site cleft is large enough to accommodate at least seven residues of a substrate, thus forming S4 through S'3 subsites. Hydrophobic and aromatic amino acids are preferred at the P1 and P'1 positions. Interactions at additional subsites are important in some cases, for example with cleavage of kappa-casein by chymosin. Two potent naturally occurring inhibitors are known: pepstatin, a pentapeptide from Streptomyces, and a unique proteinous inhibitor from Ascaris. Pepsinogen genes comprise nine exons and may be multiple, especially for pepsinogen A. The latter and progastricsin predominate in adult animals, while pepsinogen F and prochymosin are the main forms in the fetus/infant. The switching of gene expression from fetal/infant to adult-type pepsinogens during postnatal development is noteworthy, being regulated by several factors, including steroid hormones.

[Site-directed mutagenesis at disulfide bond Cys206-Cys210 of prochymosin (chymosin)].

During the work of site-directed mutagenesis at disulfide bond Cys206-Cys210 of prochymosin, it was found that the corresponding template sequence had the potential to form a loop-stem structure with free energy of -16.1 kcal/mol, which prevent the template from pairing with primer and, in turn, the synthesis of the mutated DNA strand. Rapid annealing can overcome this difficulty. Five expression plasmids of prochymosin muants with deletion of Cys206-Cys210 (C206A, C210A, C206A/C210A, C210S and C206S/C210S) were constructed. Except for C206A they were expressed at high level in E. coli amounting to 50% of the total cellular proteins. Renaturation of the mutant prochymosin indicated that Cys206-Cys210 is dispensable for correct refolding of prochymosin. However, the amino acid residues at Cys206 and/or Cys 210 play a critical role in determining the renaturation. Among the five mutants the reactivation efficiency of C206A/C210A were about 4.5-fold, 20-fold and 30-fold higher than that of C206S/C210S, C210A and C210S respectively. C206A can not correctly refold at all. CD spectra in the far UV region indicate that C206A/C210A and C206S/C210S chymosin analogs have a secondary structure almost identical to that of the wild-type chymosin. Fluorescence spectroscopic analysis revealed that mutant chymosins have the same emission maximum at 333 nm as the wild-type chymosin but their fluorescence intensities at 333 nm are much higher than that of the wild-type chymosin. Considering that the mutants and the wild-type chymosin exhibit almost the same specific activity, it is reasonable to conclude that the mutant proteins assume a native active information with a perturbance around some tryptophan residues.

The role of stasis in the clotting of blood and milk flows around solid objects.

A milk preparation has been used previously as an analogue for the study of flow related thrombosis in vitro. This paper describes further experiments to determine the comparability of milk clotting and thrombosis and to investigate the hydrodynamic correlates of milk clot deposition. An objective was to establish a standard in vitro test for thrombogenicity, thus facilitating the search for athrombogenic designs for prosthetic valves and other devices. Milk clotting in steady and pulsatile flow around four simple bodies of revolution showed many similarities of location and extent with in vivo canine thrombosis formation around similar bodies. A dye injection investigation of the fluid residence time distribution under the hydrodynamic conditions of the milk flow experiments showed that a permanent or trapped vortex persisted at each downstream site where clot was found, implying that stasis, or stagnation, is of predominant importance in causing milk clotting. Supplementary experiments with milk, using a modified Lee-White test, likewise showed that mixing promoted coagulation only after a certain fixed induction period from activation of the clotting process. Thus clot deposition is promoted by mixing which follows a constant induction period, rather than by mixing during an induction phase. This is a significant modification of the previous hypothesis.

Casein micelle size and composition related to the enzymatic coagulation process.

Chymosin (EC 3.4.23.4) and rennet, the latter containing about 85% chymosin and 15% pepsin, have been compared according to their coagulation properties with native micelles of different sizes or monomeric caseins as substrate. The casein micelles were separated on columns of controlled-pore glass (CPG-10/3000), which fractionates particles of up to 300 nm diameter. The results show that the coagulation time varies with the micelle size. The effect, which is more pronounced with chymosin than with rennet, appears to be related to the availability of kappa-casein. Therefore the largest micelles, with a lower kappa-casein content, showed longer coagulation times than medium size micelles. In the region of the smallest micelles this time increases again, probably due to an increased beta-casein content. Addition of monomeric kappa-casein decreased the coagulation time with both rennet and chymosin, but alpha s1-and beta-casein had the opposite effect. When isolated monomeric caseins were treated alone with rennet or chymosin, kappa-casein caused turbidity, but alpha s1-and beta-casein did not. Centrifugation experiments with micelles after monomeric casein addition showed that a limited amount of the added casein was able to join the micelle. This was confirmed by chromatographic studies.